Skip to Content

Join the 'Hypercalcemia of Malignancy' group to help and get support from people like you.

Hypercalcemia of Malignancy News

Could Talk Therapy Ease Chemo-Related Memory Issues?

Posted 2 May 2016 by Drugs.com

MONDAY, May 2, 2016 – A type of psychotherapy might help cancer survivors deal with the long-term thinking problems some experience after chemotherapy, researchers say. It's estimated that about half of those who undergo chemotherapy for cancer develop what's often called "chemo brain." For instance, they may have trouble following conversations or remembering the steps in a project, according ...

U.S. Oncologists Decry High Cost of Cancer Drugs

Posted 23 Jul 2015 by Drugs.com

THURSDAY, July 23, 2015 – Soaring costs for cancer drugs are hurting patient care in the United States, a group of top oncologists claim. "High cancer-drug prices are affecting the care of patients with cancer and our health care system," Dr. Ayalew Tefferi, a hematologist at Mayo Clinic in Rochester, Minn., said in a Mayo news release. Tefferi and his colleagues made a number of recommendations ...

FDA Approves Xgeva (denosumab) for Hypercalcemia of Malignancy Refractory to Bisphosphonate Therapy

Posted 8 Dec 2014 by Drugs.com

THOUSAND OAKS, Calif., Dec. 8, 2014 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Xgeva (denosumab) for the treatment of hypercalcemia of malignancy (HCM) refractory to bisphosphonate therapy. Xgeva was approved and granted Orphan Drug Designation by the FDA, which is reserved for drugs that are intended for ...

FDA Medwatch Alert: Sensipar (Cinacalcet Hydrochloride): Drug Safety Communication - FDA Suspends Pediatric Clinical Trials After Report Of Death

Posted 26 Feb 2013 by Drugs.com

ISSUE: FDA has stopped all pediatric clinical trials of Sensipar (cinacalcet hydrochloride) after the recent death of a 14-year-old patient in a trial.  Posting this information does not mean that FDA has concluded whether or not Sensipar had a role in the patient’s death. This communication is intended to inform health care professionals that we are evaluating the information and will co ...

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

prednisone, dexamethasone, Reclast, Xgeva, Zometa, Decadron, Aclasta, Sensipar, denosumab, view more... Deltasone, zoledronic acid, Sterapred, gallium nitrate, Sterapred DS, Orasone, Liquid Pred, Prednicen-M, Prednicot, Didronel IV, cinacalcet, Dalalone LA, Dexamethasone Intensol, Adrenocot LA, Baycadron, Dalalone, Dalalone DP, Decaject, Decaject LA, Zema Pak, Zonacort, Meticorten, Primethasone, Dexpak Taperpak, Dexacen-4, etidronate, pamidronate, Didronel, Aredia, Ganite, Hexadrol, Decadron-LA, Solurex LA, Solurex, Medidex LA, Adrenocot, De-Sone LA, Dexacort-LA, Dexasone, Dexasone LA, Dexone, Dexone LA, Dexacorten, Medidex, LoCort